Sign in

CIK 0001022079

  • Large accelerated filer

QUEST DIAGNOSTICS INC

Sign in to watch
Ticker
DGX
Exchange
NYSE
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
161387862
Phone
+1 973-520-2700
Business address
500 PLAZA DRIVE, SECAUCUS, NJ, 07094
Former names
CORNING CLINICAL LABORATORIES INC
  1. 4 Grant or award Executive Vice President & CFO acquired 108 shares (grant or award)
  2. 4 Other acquisition SVP for Diagnostic Services acquired 49 shares (code L)
  3. 4 Grant or award Director acquired 68 shares (grant or award)
  4. 4 Other acquisition Director acquired 7 shares (code L)
  5. 4 Other acquisition Director acquired 6 shares (code L)
  6. 4 Other acquisition SVP, Clinical Solutions acquired 39 shares (code L)
  7. 4 Other acquisition SVP & Chief Commercial Officer acquired 37 shares (code L)
  8. 4 Derivatives Options or other derivatives
  9. 4 Grant or award Director acquired 215 shares (grant or award)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Grant or award Executive Vice President & CFO acquired 13,947 shares (grant or award)
  12. 4 Planned sale EVP, Regional Businesses sold 5,558 shares at $206.21 ($1,146,115)
  13. 4 Grant or award SVP & Chief Commercial Officer acquired 5,682 shares (grant or award)
  14. 4 Planned sale SVP & General Counsel sold 3,878 shares at $206.21 ($799,682)
  15. 4 Grant or award CEO and President acquired 51,652 shares (grant or award)
  16. 4 Planned sale SVP for Diagnostic Services sold 2,855 shares at $206.21 ($588,730)
  17. 4 Grant or award SVP, Corp. Controller & CAO acquired 1,473 shares (grant or award)
  18. 4 Open-market sale SVP, Clinical Solutions sold 2,628 shares at $204.86 ($538,372)
  19. 4 Planned sale EVP, Regional Businesses sold 632 shares at $207.73 ($131,285)
  20. 4 Shares withheld for taxes Executive Vice President & CFO gave up 869 shares (to pay taxes)

Page 3 of 74 · 1,466 filings